Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

  1. Karp, D.D.
  2. Pollak, M.N.
  3. Cohen, R.B.
  4. Eisenberg, P.D.
  5. Haluska, P.
  6. Yin, D.
  7. Lipton, A.
  8. Demers, L.
  9. Leitzel, K.
  10. Hixon, M.L.
  11. Terstappen, L.W.
  12. Garland, L.
  13. Paz-Ares, L.G.
  14. Cardenal, F.
  15. Langer, C.J.
  16. Gualberto, A.
Revue:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Année de publication: 2009

Volumen: 4

Número: 11

Pages: 1397-1403

Type: Article

DOI: 10.1097/JTO.0B013E3181BA2F1D GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus